Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-29 Option Award |
2025-01-31 4:31 pm |
N/A 2035-01-29 |
Merus N.V. | MRUS | PERRY GREGORY D Chief Financial Officer & PFO |
100,000 | $0 | 100,000 (Direct) |
View |
2024-06-11 Option Award |
2024-06-12 8:00 pm |
N/A 2034-06-10 |
KALA BIO Inc. | KALA | PERRY GREGORY D Director |
4,550 | $0 | 14,044 (Direct) |
View |
2024-05-07 Option Award |
2024-05-09 4:30 pm |
N/A 2034-01-31 |
Merus N.V. | MRUS | PERRY GREGORY D Chief Financial Officer & PFO |
107,300 | $0 | 107,300 (Direct) |
View |
2023-06-22 Option Award |
2023-06-23 8:00 pm |
N/A 2033-06-21 |
Kala Pharmaceuticals Inc. | KALA | PERRY GREGORY D Director |
17,264 | $0 | 19,802 (Direct) |
View |
2023-06-14 Option Award |
2023-06-15 4:23 pm |
N/A 2033-06-14 |
Merus N.V. | MRUS | PERRY GREGORY D Chief Financial Officer |
372,924 | $0 | 372,924 (Direct) |
View |
2023-06-08 Option Award |
2023-06-12 4:14 pm |
N/A 2033-06-08 |
Merus N.V. | MRUS | PERRY GREGORY D Director |
14,414 | $0 | 14,414 (Direct) |
View |
2023-05-31 Option Award |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | PERRY GREGORY D Director |
1,738 | $0 | 2,538 (Direct) |
View |
2022-06-16 Option Award |
2022-06-17 4:45 pm |
N/A 2032-06-15 |
Kala Pharmaceuticals Inc. | KALA | PERRY GREGORY D Director |
40,000 | $0 | 40,000 (Direct) |
View |
2022-05-31 Option Award |
2022-06-02 4:05 pm |
N/A 2032-05-31 |
Merus N.V. | MRUS | PERRY GREGORY D Director |
16,604 | $0 | 16,604 (Direct) |
View |
2022-02-25 Option Award |
2022-02-28 6:50 pm |
N/A 2032-02-24 |
Finch Therapeutics Group Inc. | FNCH | PERRY GREGORY D Chief Financial Officer |
80,000 | $0 | 80,000 (Direct) |
View |
2021-06-17 Option Award |
2021-06-21 5:30 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | PERRY GREGORY D Director |
20,000 | $0 | 40,000 (Direct) |
View |
2021-05-28 Option Award |
2021-06-02 4:10 pm |
N/A 2031-05-28 |
Merus N.V. | MRUS | PERRY GREGORY D Director |
6,120 | $0 | 6,120 (Direct) |
View |
2021-03-18 Option Award |
2021-03-18 9:30 pm |
N/A 2031-03-17 |
Finch Therapeutics Group Inc. | FNCH | PERRY GREGORY D Chief Financial Officer |
55,386 | $0 | 55,386 (Direct) |
View |
Ownership |
2021-03-18 9:19 pm |
N/A 2028-05-06 |
Finch Therapeutics Group Inc. | FNCH | PERRY GREGORY D Chief Financial Officer |
0 | $0 | 304,254 (Direct) |
View |
2020-06-30 Option Award |
2020-07-02 4:00 pm |
N/A 2030-06-30 |
Merus N.V. | MRUS | PERRY GREGORY D Director |
8,631 | $0 | 8,631 (Direct) |
View |
2020-06-25 Option Award |
2020-06-29 9:55 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | PERRY GREGORY D Director |
20,000 | $0 | 20,000 (Direct) |
View |